Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003505900 | SCV004260625 | pathogenic | Imerslund-Grasbeck syndrome | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly196Alafs*3) in the AMN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AMN are known to be pathogenic (PMID: 12590260, 22929189). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with AMN-related conditions. For these reasons, this variant has been classified as Pathogenic. |